Trials / Completed
CompletedNCT04825574
Study for Patients Previously Treated in Avapritinib Clinical Trials
Extension Protocol for Patients Previously Treated in Avapritinib Clinical Trials
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 2 (actual)
- Sponsor
- Blueprint Medicines Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an open-label extension study to provide long term safety data for GIST patients who are deriving clinical benefit from avapritinib upon the completion of avapritinib clinical trials.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Avapritinib | avapritinib tablet |
Timeline
- Start date
- 2021-05-21
- Primary completion
- 2023-11-23
- Completion
- 2023-11-23
- First posted
- 2021-04-01
- Last updated
- 2024-11-26
- Results posted
- 2024-11-26
Locations
1 site across 1 country: France
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04825574. Inclusion in this directory is not an endorsement.